Share
CNBC Pro

Watch CNBC's full interview with Merck CEO Rob Davis on $11.5 billion Acceleron acquisition

Merck CEO Rob Davis joins CNBC's Meg Tirrell to discuss the company's major acquisition of Acceleron Pharma valued at $11.5 billion and provides an update on Merck's highly anticipated Covid-19 pill.
11:53
Thu, Sep 30 20217:35 AM EDT

watch now
VIDEO44:23
CNBC ProWatch Tuesday's full episode of the Halftime Report — November 30, 2021
watch now
VIDEO07:20
CNBC ProWatch CNBC's full interview with Jefferies' David Zervos on Powell's testimony today
watch now
VIDEO07:16
CNBC ProWatch CNBC's full interview with Fundstrat's Tom Lee on Powell's testimony today
watch now
VIDEO06:49
CNBC ProWatch CNBC's full interview with Schwab Asset Management's Omar Aguilar
watch now
VIDEO10:50
CNBC ProWatch CNBC's full interview with Regeneron CEO Dr. Leonard Schleifler